How should a pregnant patient with thalassemia and normal iron stores be managed?

Management of Thalassemia in Pregnancy with Normal Iron Stores

Pregnant patients with thalassemia and normal iron stores require regular transfusions to maintain hemoglobin ≥10 g/dL, cessation of iron chelation therapy, cardiac monitoring throughout pregnancy, and thromboprophylaxis particularly if splenectomized, with management best coordinated by a multidisciplinary team at an expert center. 1

Preconception Assessment

Before conception, all women with thalassemia major should undergo comprehensive cardiac evaluation including: 1

• Cardiac T2 MRI to assess myocardial iron concentration*
• Echocardiography for cardiac function and chamber dimensions
• Assessment of liver iron concentration

This baseline cardiac assessment is critical because even with normal iron stores, pregnancy-related hemodynamic changes (increased blood volume, altered blood pressure) can compromise cardiac function. 1

Transfusion Management During Pregnancy

Maintain hemoglobin at approximately 10 g/dL throughout pregnancy to ensure optimal fetal growth. 1

• Blood consumption typically increases during pregnancy in thalassemia major patients 1
• In thalassemia intermedia, approximately 70% of pregnancies require blood transfusions despite being non-transfusion-dependent pre-pregnancy 2
• Recent meta-analysis shows red cell requirements increase significantly from 102 to 139 mL/kg/year during pregnancy in thalassemia major 2

Critical caveat: Women with thalassemia intermedia who have never been transfused or received minimal transfusions are at high risk of severe alloimmune anemia if blood transfusions become necessary during pregnancy. 3

Iron Chelation Management

Iron chelation therapy must be discontinued during pregnancy due to teratogenic concerns. 1

However, the combination of increased transfusions and cessation of chelation significantly worsens iron overload during pregnancy: 1, 2

• Serum ferritin increases by approximately 1005 ng/mL in thalassemia major 2
• Liver iron concentration increases from 4.6 to 11.9 mg/g dry weight 2
• Myocardial T2* decreases from 36.2 ms to 31.1 ms during pregnancy 2

Exception for severe iron overload: In patients with severe cardiac or hepatic iron overload, restarting deferoxamine toward the end of the second trimester should be considered when potential maternal benefits outweigh fetal risks. 1, 3

Cardiac Monitoring Throughout Pregnancy

Cardiac function must be monitored carefully throughout pregnancy given the 1.1-15.6% rate of cardiac complications. 1

The increased risk stems from: 1

• Worsening iron overload despite normal baseline stores
• Pregnancy-related hemodynamic changes
• Increased blood volume and blood pressure alterations

Women with preexisting cardiac disease or significant cardiac iron face the highest maternal risk. 1

Thromboprophylaxis

Prophylaxis for thromboembolism with heparin or low-molecular-weight heparin is indicated, particularly in: 1

• Splenectomized patients
• Patients with thalassemia intermedia (who have higher baseline thrombotic risk of 3.7% vs 0.92% in thalassemia major) 2

Pregnancy increases thrombosis risk 3-4 fold, and thalassemia itself is a hypercoagulable state, creating compounded risk. 3

Monitoring for Obstetric Complications

Pregnant women with thalassemia face increased rates of: 1

• Gestational diabetes (3.9%) 2
• Pre-eclampsia (11.3%) 2
• Preterm birth 1
• Spontaneous miscarriage and fetal loss (9-33.3%) 1

Delivery Planning

Cesarean delivery rates are high (67-100%) due to: 1

• Fetopelvic disproportion
• Maternal osteoporosis
• Maternal HIV infection
• Patient preference

Postpartum Management

Immediately resume iron chelation therapy postpartum to address the significant iron accumulation that occurred during pregnancy. 2

Expert Center Management

These pregnancies must be managed at expert centers with a multidisciplinary team including: 1

• Hematologist with thalassemia expertise
• Cardiologist experienced in iron-related cardiac disease
• High-risk obstetrician
• Endocrinologist

The American Heart Association emphasizes that favorable pregnancy outcomes are only achievable when this comprehensive team approach is available, given the substantially increased risk to both mother and baby. 1